Search results
Results from the WOW.Com Content Network
The Milwaukee brace, also known as a cervico-thoraco-lumbo-sacral orthosis or CTLSO, is a back brace most often used in the treatment of spinal curvatures (such as scoliosis or kyphosis) in children but also, more rarely, in adults to prevent collapse of the spine and associated pain and deformity. It is a full-torso brace that extends from the ...
Elivaldogene autotemcel, sold under the brand name Skysona, is a gene therapy used to treat cerebral adrenoleukodystrophy (CALD). It was developed by Bluebird Bio and was given breakthrough therapy designation by the US Food and Drug Administration in May 2018.
The price for the treatment was set at €594,000, twice the annual cost of enzyme replacement therapy injections. [20] Enzyme replacement therapy for ADA requires weekly injections and costs about US$4.25 million for one patient over ten years.
The Boston brace, a type of thoraco-lumbo-sacral-orthosis (TLSO), [1] is a back brace used primarily for the treatment of idiopathic scoliosis in children. [2] It was developed in 1972 by M.E "Bill" Miller and John Hall at the Boston Children's Hospital in Boston , Massachusetts .
Intravenous therapy (abbreviated as IV therapy) is a medical technique that administers fluids, medications and nutrients directly into a person's vein.The intravenous route of administration is commonly used for rehydration or to provide nutrients for those who cannot, or will not—due to reduced mental states or otherwise—consume food or water by mouth.
Alipogene tiparvovec was expected to cost around US$1.6 million per treatment in 2012, [9] —revised to $1 million in 2015, [10] —making it the most expensive medicine in the world at the time. [11] However, replacement therapy, a similar treatment, can cost over $300,000 per year, for life. [4]
In an analysis of the drug development costs for 98 companies over a decade, the average cost per drug developed and approved by a single-drug company was $350 million. [3] But for companies that approved between eight and 13 drugs over 10 years, the cost per drug went as high as $5.5 billion.
Of these, proton therapy is by far the most common, though still rare compared to other forms of external beam radiotherapy, since it requires large and expensive equipment. The gantry (the part that rotates around the patient) is a multi-story structure, and a proton therapy system can cost (as of 2009) up to US$150 million. [9]